Severe Toxicity with a Generic Formulation of Zoledronic Acid: A Case Report
Intravenous zoledronic acid (ZOL) is an integral component for the management of patients with bone metastases, but can be associated with transient flu-like symptoms, which generally occur only with the first infusion and are typically manageable with non-prescription analgesics. A 50-year-old woma...
Main Author: | Benito Sanchez |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-01-01
|
Series: | Clinical Medicine Insights: Case Reports |
Online Access: | https://doi.org/10.4137/CCRep.S8825 |
Similar Items
-
Severe Toxicity with a Generic Formulation of Zoledronic Acid: A Case Report
by: Benito Sanchez
Published: (2012-10-01) -
Symptomatic Hypocalcemia Associated with Zoledronic Acid Treatment for Osteoporosis: A Case Report
by: Abdulmohsen H. Al Elq
Published: (2013-03-01) -
Short-term intravenous zoledronic acid in severe osteogenesis imperfecta : A report of three siblings of children
by: Hadyanto Lim, et al.
Published: (2008-05-01) -
Zoledronic acid for the treatment of pregnancy-associated femoral head necrosis: A case report
by: Estella Musacchio, et al.
Published: (2020-04-01) -
Acute unilateral anterior uveitis following zoledronic acid infusion: A case report
by: Kiruththihan Anandasayanan, et al.
Published: (2020-07-01)